Diagnostic Accuracy of Cell Block Preparations and Clinical Features Affecting It in Vitreoretinal Lymphoma
- PMID: 35268483
- PMCID: PMC8911042
- DOI: 10.3390/jcm11051391
Diagnostic Accuracy of Cell Block Preparations and Clinical Features Affecting It in Vitreoretinal Lymphoma
Abstract
Purpose: The purpose of this study was to examine the diagnostic accuracy of the cell block (CB) method and clinical features affecting it in patients with vitreoretinal lymphoma (VRL). Methods: This study enrolled 38 eyes in 33 VRL patients, and 7 eyes in 7 patients with idiopathic uveitis who underwent diagnostic vitrectomy. Medical records including the results of CB cytology, interleukin (IL)-10/-6 concentrations, and immunoglobulin heavy chain gene (IgH) rearrangement were retrospectively searched. Results: Patients with VRL comprised 16 women and 17 men, and the age of onset ranged from 44 to 85 years (mean: 70 years). CB preparations detected large malignant cells in 35 eyes (92%), whereas the other 3 VRL eyes were negative. Two of the latter three eyes showed subretinal infiltrates, which existed in 7 of 35 CB-positive eyes. Intravitreal IL-10 and -6 concentrations were 1866 ± 4088 pg/mL and 98 ± 139 pg/mL, respectively, and the rate of IL-10/-6 >1 was 86.9%. The presence of IgH monoclonality was 63.2%. In patients with uveitis, CB specimens revealed no atypical but small inflammatory cells. IL-6 concentration was 311.1 ± 240 pg/mL, whereas IL-10 was undetectable in six eyes, and the IL-negative rate was 85.7%. Six eyes (85.7%) with uveitis showed no IgH monoclonality. Conclusions: Diagnostic accuracy of CB preparations in VRL could achieve an equivalent outcome to IL ratio calculation and IgH monoclonality detection. The appearance of subretinal infiltrates may diminish the CB positivity.
Keywords: cell block preparations; optical coherence tomography; subretinal infiltrates; vitreoretinal lymphoma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Diagnostic efficacy of cell block method for vitreoretinal lymphoma.Diagn Pathol. 2016 Mar 17;11:29. doi: 10.1186/s13000-016-0479-1. Diagn Pathol. 2016. PMID: 26987877 Free PMC article.
-
Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.Invest Ophthalmol Vis Sci. 2023 Nov 1;64(14):27. doi: 10.1167/iovs.64.14.27. Invest Ophthalmol Vis Sci. 2023. PMID: 37975847 Free PMC article.
-
Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):412-7. doi: 10.1016/j.clml.2012.07.006. Epub 2012 Sep 18. Clin Lymphoma Myeloma Leuk. 2012. PMID: 22995952
-
Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches.Prog Retin Eye Res. 2022 Sep;90:101053. doi: 10.1016/j.preteyeres.2022.101053. Epub 2022 Feb 21. Prog Retin Eye Res. 2022. PMID: 35210172 Review.
-
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma.Ocul Immunol Inflamm. 2021 Apr 3;29(3):507-520. doi: 10.1080/09273948.2021.1878233. Epub 2021 May 19. Ocul Immunol Inflamm. 2021. PMID: 34009095
Cited by
-
Electroretinographic and Optical Coherence Tomographic Evaluations of Eyes with Vitreoretinal Lymphoma.J Clin Med. 2023 Jun 9;12(12):3957. doi: 10.3390/jcm12123957. J Clin Med. 2023. PMID: 37373651 Free PMC article.
References
-
- Chan C.-C., Rubenstein J.L., Coupland S.E., Davis J.L., Harbour J.W., Johnston P.B., Cassoux N., Touitou V., Smith J.R., Batchelor T.T., et al. Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium. Oncologist. 2011;16:1589–1599. doi: 10.1634/theoncologist.2011-0210. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources